Hyndburn Diabetes Focus Group
IMO Charity is currently recruiting people diagnosed with diabetes, living with someone in your household who has diabetes or at risk of diabetes to take part in a Focus Groups on self-management and prevention.
They are particularly keen to talk to members of the BAME community in Hyndburn who have diabetes or live with someone who does. The invite to attend their Diabetes Focus Groups will help them understand your condition and the challenges you face. By taking part you can help shape future services and help others.
The focus groups will run via ZOOM, which will last no longer than one and a half hours. We have initially agreed to run the focus groups on the following two dates and times. We are asking you to attend only one of the two dates below.
- Wednesday 17th March 2021 at 6.30pm
- Saturday 20th March 2021 at 1.30pm
By participating in one of the focus groups, you will be able to help improve how the Diabetes services could be delivered in the future to meet the needs of BAME communities.
More background information will be sent to those reserving their place before the focus group dates.
If you would like to take part in any of our community focus groups, please let us know by contacting Mohammed Amad on 01254 781310 or by sending a TEXT 07713 028295 or via EMAIL Mohammed.Amad@imocharity.org
Type 2 diabetes mellitus (T2DM) is a chronic and debilitating disease characterised by elevated blood glucose through insulin resistance, relative impairment of insulin secretion and increased hepatic glucose output. In the short term, the symptoms of T2DM are associated with a reduced quality of life, whereas in the longer term the disease may lead to serious complications such as cardiovascular disease (CVD), blindness, renal failure and amputation.
The life expectancy of individuals with T2DM may be shortened by as much as 10 years, with up to 75% of individuals dying of CVD.
The prevalence of T2DM has risen so steeply over the past few decades that it is now commonly referred to as an epidemic, and elevated blood glucose levels are currently estimated to be the third leading modifiable cause of mortality globally.
Currently, in the UK, diabetes mellitus currently accounts for approximately 10% of the total health-resource expenditure, which is projected to increase to around 17% in 2035/36.